1. Introduction {#sec1-molecules-22-00860}
===============

C~21~-Pregnane-type natural organic compounds possess the usual skeleton of 17-ethyl-10,13-dimethylhexadecahydro-1*H*-cyclopenta\[*a*\]phenanthrene on the systematic nomenclature. The natural resource of this class of steroids is very affluent in the plant world, with both sugar-free and glycosidated pregnane-type steroids having been isolated by many researchers through phytochemical methods. In addition to the usual four-ring C~21~-pregnane-type skeleton, there are also several unusual skeletons, such as the 8,14-seco-C~21~-pregnane-type, 14,15-seco-C~21~-pregnane-type, and 13,14:14,15-diseco-C~21~-pregnane-type skeletons, all of these usual and unusual skeletons possessing multiple stereogenic centers and other structural diversities \[[@B1-molecules-22-00860],[@B2-molecules-22-00860],[@B3-molecules-22-00860]\]. It is well known that the *Cynanchum* species of the Asclepiadaceae family are very rich in C~21~-steroids, with the unusual 14,15-seco-C~21~-pregnane-type and 13,14:14,15-diseco-C~21~-pregnane-type skeletons being most often discovered in previous investigations \[[@B4-molecules-22-00860],[@B5-molecules-22-00860],[@B6-molecules-22-00860],[@B7-molecules-22-00860],[@B8-molecules-22-00860],[@B9-molecules-22-00860],[@B10-molecules-22-00860],[@B11-molecules-22-00860]\]. It is also well known in natural medicinal chemistry that, in addition to the structural diversity, C~21~-steroids are one class of biologically active compounds, with multiple bioactivities being reported \[[@B7-molecules-22-00860],[@B9-molecules-22-00860],[@B10-molecules-22-00860],[@B11-molecules-22-00860],[@B12-molecules-22-00860]\]. Especially, our group reported that some steroidal glycosides isolated from *C. stauntonii* (Decne.) Schltr. ex Levl., a perennial medicinal herb naturally growing in the south-central region of China, showed anti-inflammatory activity \[[@B3-molecules-22-00860]\]. This finding provided evidence supporting the application of *C. stauntonii* in some traditional medicine systems to treat inflammations \[[@B3-molecules-22-00860],[@B13-molecules-22-00860],[@B14-molecules-22-00860]\]. Following the isolation and identification of several steroidal glycosides from the roots of *C. stauntonii* sharing the first reported aglycones of 8α:14α,14:16,15:20,18:20-tetraepoxy-14,15-secopregn-6-ene-3β,5α,9α-triol or its 5α:9α-peroxy bridge structure \[[@B3-molecules-22-00860]\], our ongoing searches for new steroids in the same subjects lead to the isolation of three new steroidal glycoside, stauntosides UA, UA~1~, and UA~2~ (**1**--**3**) ([Figure 1](#molecules-22-00860-f001){ref-type="fig"}). Structural identification affirmed that stauntosides UA, UA~1~, and UA~2~ shared an aglycone of 3β-hydroxy-5α:9α-peroxy-14:16,15:20,18:20-triepoxy-14,15-secopregnane-6, 8(14)-diene, similar to, but somewhat different from the aforementioned first reported aglycones. Thus, the three new steroids were regarded as another subcategory of 14,15-secopregnane-type steroids. In order to grace the structural diversity of pregnane-type steroids in *C. stauntonii*, this paper describes the isolation and structure elucidation of these new compounds.

2. Results and Discussion {#sec2-molecules-22-00860}
=========================

The roots of *C. stauntonii* were extracted with 95% EtOH. The 95% EtOH extract was concentrated and partitioned using petroleum ether and EtOAc. The EtOAc-soluble fraction was separated using multiple column chromatographies and preparative HPLC. As a result, three new compounds reported herein were yielded, all as white amorphous powders. All three compounds showed positive Libermann-Burchard and Keller-Kiliani reactions, suggesting their glycosidated steroids or triterpenoids categories with 2-deoxysugars in their sugar moieties \[[@B2-molecules-22-00860],[@B15-molecules-22-00860]\]. The category of steroidal glycosides was determined according to their shared common features in the NMR spectra. The three or four distinguishable anomeric proton signals of sugars in the ^1^H-NMR spectra indicated the presence of corresponding sugar moieties ([Table 1](#molecules-22-00860-t001){ref-type="table"}). When putting off the carbon signals of the three or four hexose units, all three compounds left twenty-one carbons from the C~21~-pregnane moieties ([Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}). All three compounds showed two singlets of methyl groups in their ^1^H-NMR spectra. The δ values of the relatively lower-field singlet of methyl groups in each compound, i.e., δ~H~ 1.54 for all three compounds, along with the carbon signals at δ~C~ 118.4, 119.6, and 118.2 in the ^13^C-NMR spectra for compounds **1**--**3**, respectively, suggested that they belonged to the unusual 14,15-seco- (or 13,14:14,15-diseco-) C~21~-pregnane-type steroids. These singlets of methyl groups in the ^1^H-NMR spectra were born of Me-19 and 21 of the C~21~-pregnane skeleton, respectively. These carbon signals are the typical features of a dioxygenated secondary carbon-20 structure and they were confirmed by the correlations from Me-21 to C-17 and 20 in the respective HMBC spectrum of the three compounds. No carbonyl carbon was present in the ^13^C-NMR spectra of all three compounds, assigning them to be the 14,15-seco-C~21~-pregnane-type steroids \[[@B2-molecules-22-00860],[@B3-molecules-22-00860],[@B7-molecules-22-00860]\].

Compound **1** possessed a molecular formula of C~40~H~58~O~15~ according to its ^13^C-NMR spectroscopic data and the HRESIMS (positive ion mode) data for the protonated molecular ion at *m*/*z* 779.3861 and sodium adduct molecular ion at *m*/*z* 801.3694, indicating a hydrogen deficiency index of twelve. This molecular formula has one fewer oxygen atom than that of stauntoside V~3~, a 14,15-secopregnane-type glycoside with the aglycone of stauntogenin F (3β-hydroxy-8α:14α,14:16,15:20,18:20-tetraepoxy-5α:9α-peroxy-14,15-secopregn-6-ene) previously isolated by our group from *C. stauntonii* \[[@B3-molecules-22-00860]\]. Its IR spectrum displayed absorption bands for hydroxy (3440 cm^−1^) and olefinic (1681 cm^−1^) functionalities, among others. Acid hydrolysis, along with derivatization and GC analysis, indicated the presence of [d]{.smallcaps}-canaropyranose, [d]{.smallcaps}-digitoxopyranose, and [l]{.smallcaps}-cymaropyranose in a 1:1:1 ratio. The entire ^1^H and ^13^C-NMR spectroscopic data for **1** are given in [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}, respectively. A detailed comparison of NMR data between **1** and stauntoside V~3~ showed that they were very similar. In the ^1^H-NMR spectrum, all the signals for **1** were nearly superimposable on their counterparts in stauntoside V~3~, the coupling constants of the three anomeric protons provided evidence that two monosaccharides shared β-glucosidic bonds and one possessed an α*-*glucosidic bond. In the ^13^C-NMR spectrum, the primary difference was in the replacement of the signals for an oxygenated tertiary carbon at δ~C~ 70.8 (s, C-8) and an dioxygenated secondary carbon at δ~C~ 98.9 (s, C-14) in the known compound by the signals of an olefinic quaternary carbon at δ~C~ 110.4 (C-8) and an oxygenated olefinic tertiary carbon at δ~C~ 156.8 (s, C-14) in **1**. The rest of the carbons of compound **1** showed full accordance with categories of carbon types with their respective counterparts in stauntoside V~3~. The conjugated highfield shifts of C-6 and C-7 by Δ~δ~ --10.9 and −2.7, respectively, in compound **1** compared with stauntoside V~3~ were evident, which proposed a double bond linkage between C-8 and C-14. A highfield shift of Δ~δ~ --6.2 for C-10 compared with stauntoside V~3~ was also observed, which was mainly due to the impact of the change of magnetic anisotropy from the 8:14-epoxy linkage (oxirane) in stauntoside V~3~ to the Δ^8(14)^ structure in **1**. For the rest of carbon atoms, except for C-12 and C-18 which, because of the same causes as C-10, showed up lowfield shifts of Δ~δ~ +1.4 and +1.82, respectively, the numerical range of the absolute values of Δ~δ~ compared with the corresponding carbons in stauntoside V~3~ were less than 1.0, including those of the sugar moieties. These consistencies and differences of functional groups and chemical shifts between **1** and stauntoside V~3~, especially the molecular formula with a hydrogen deficiency index of twelve, indicated the presence of the peroxo bridge structure between C-5 and C-9, just as in stauntoside V~3~. Further, this identification was confirmed by the finding that the peroxylated downfield chemical shifts of Δ~δ~ +11.8 and +11.1 were observed for C-5 and C-9, respectively, in the ^13^C-NMR spectrum compared with stauntoside U, another 14,15-secopregnane-type glycoside with the aglycone of stauntogenin E (8α:14α,14:16,15:20,18:20-tetraepoxy-14,15-secopregn-6-ene-3β,5α,9α-triol) previously isolated by our group from *C. stauntonii* \[[@B3-molecules-22-00860]\]. The HMBC spectrum showed the same picture as those in stauntoside V~3~, with the following correlations being well-marked: H-6 to C-4, 5, 8, and 10; H-7 to C-5, 9, and 14; H-15a to C-16, 17, and 20; H-17 to C-12, 13, 14, 18, and 20; H-18a to C-12 and 14; H-18b to C-12, 14, 17, and 20; Me-19 to C-1, 5, 9, and 10; Me-21 to C-17 and 20; H-1′′′ of α-[l]{.smallcaps}-cymaropyranose to C-4′′ of β-[d]{.smallcaps}-digitoxopyranose; H-1′′ of β-[d]{.smallcaps}-digitoxopyranose to C-4′ of β-[d]{.smallcaps}-canaropyranose; and H-1′ of β-[d]{.smallcaps}-canaropyranose to C-3, among others ([Figure 2](#molecules-22-00860-f002){ref-type="fig"}). The typical relative configurations of 14,15-secopregnane-type steroids of compound **1**, i.e., both CH~2~-18 and Me-19 in β-orientation and H-16, H-17, and Me-21 all in α-orientation, which was also the same as that of stauntoside V~3~, were affirmed in the NOESY spectrum by the same picture as those of stauntoside V~3~, with NOE correlations of H-3/H-2α, H-3/H-4α, H-6/H-4α, H-6/H-4β, H-6/H-7, H-6/Me-19, H-7/Me-19, H-15α/H-17, H-16/H-17, H-17/Me-21, and Me-19/H-11β being evident and NOE correlations between H-3 and H-1α, H-3 and H-1β, H~2~-18 and Me-21, H~2~-18 and H-17, and Me-19 and H-4α not being observed ([Figure 3](#molecules-22-00860-f003){ref-type="fig"}). Especially, the relative configurations of 5α:9α-peroxy linkage and H-3α were elucidated by the same picture of reciprocal NOE correlations of H-3, H-6, H-7, and Me-19 ([Figure 3](#molecules-22-00860-f003){ref-type="fig"}), among others, with relevant protons as in stauntoside V~3~. Thus, the aglycone was elucidated as 3β-hydroxy-14:16,15:20,18:20-triepoxy-5α:9α-peroxy-14,15-secopregnane-6,8(14)-diene according to the number system of pregnanes and was named as stauntogenin G, and the structure of compound **1** was characterized as 14:16,15:20,18:20-triepoxy-5α:9α-peroxy-14,15-secopregn-6,8(14)-dien-3β-yl-4-*[o]{.smallcaps}*-(4-*[o]{.smallcaps}*-α-[l]{.smallcaps}-cymaropyranosyl-β-[d]{.smallcaps}-digitoxopyranosyl)-β-[d]{.smallcaps}-canaropyranoside and named stauntoside UA.

Compound **2** possessed a molecular formula of C~49~H~74~O~19~ according to its ^13^C-NMR data and the HRESIMS (positive ion mode) of the sodium adduct molecular ion at *m*/*z* 989.4729, indicating a hydrogen deficiency index of thirteen. Its IR spectrum displayed absorption bands for hydroxy (3393 cm^−1^) and olefinic (1646 cm^−1^) functionalities. Acid hydrolysis of **2**, along with derivatization and GC analysis, indicated the presence of [d]{.smallcaps}-thevetopyranose, [d]{.smallcaps}-cymaropyranose, and [l]{.smallcaps}-diginopyranose in a 1:2:1 ratio. A detailed comparison of the ^1^H- and ^13^C-NMR data between **1** and **2** showed that **2** was nearly entirely identical to **1**, with respect to their aglycone moieties ([Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}), the numerical range of Δ~δ~ for all the ^13^C-NMR signals of the aglycone of **2** compared with the corresponding carbons in **1** was between +1.1 and +1.6, which were obviously systematic errors, suggesting the same aglycone for **2** and **1**. This determination was confirmed with a combined interpretation of the 2D NMR spectra of **2**, including the ^1^H,^1^H-COSY, HSQC, and HMBC correlations (data not shown). In addition to the resonances of the aglycone moiety, the ^1^H and ^13^C-NMR data ([Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}) and the 2D NMR spectroscopic features, including the ^1^H,^1^H-COSY and HMBC correlations, among others, of the sugar moiety of **2** were consistent with stauntoside V~1~, a 14,15-secopregnane-type glycoside previously isolated by our group from *C. stauntonii* \[[@B3-molecules-22-00860]\]. Thus, the structure of **2** is 14:16,15:20,18:20-triepoxy-5α:9α-peroxy-14,15-secopregn-6,8(14)-dien-3β-yl-4-*O*-\[4-*O*-(4-*O*-α-[l]{.smallcaps}-diginopyranosyl-β-[d]{.smallcaps}-cymaropyranosyl)-β-[d]{.smallcaps}-cymaropyranosyl\]-β-[d]{.smallcaps}-thevetopyranoside and named stauntoside UA~1~.

Compound **3** possessed a molecular formula of C~48~H~72~O~19~ according to its ^13^C-NMR data and the HRESIMS (positive ion mode) of the sodium adduct molecular ion at *m*/*z* 975.4567, indicating a hydrogen deficiency index of thirteen. Its IR spectrum displayed absorption bands for hydroxy (3369 cm^−1^) and olefinic (1662 cm^−1^) functionalities. Acid hydrolysis of **3**, along with derivatization and GC analysis, indicated the presence of [d]{.smallcaps}-thevetopyranose, [d]{.smallcaps}-digitoxopyranose, [d]{.smallcaps}-cymaropyranose, and [l]{.smallcaps}-diginopyranose in a 1:1:1:1 ratio. A detailed comparison of the ^1^H- and ^13^C-NMR data of **1**--**3** indicated that they shared the same aglycone, compound **3** being nearly entirely identical to **1** and **2**, with respect to their aglycone moieties and the numerical range of Δ~δ~ for all the ^13^C-NMR signals of the aglycone of **3** compared with the corresponding carbons in **2** being between −1.4 and −1.6 ([Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}). This determination was confirmed with a combined interpretation of the 2D NMR spectra of **3**, including the ^1^H,^1^H-COSY, HSQC, and HMBC correlations (data not shown). In addition to the resonances of the aglycone moiety, the ^1^H- and ^13^C-NMR data ([Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}) and the 2D NMR spectroscopic features, including the ^1^H,^1^H-COSY and HMBC correlations, among others, of the sugar moiety of **3** were consistent with stauntoside W, a 14,15-secopregnane-type glycoside previously isolated by our group from *C. stauntonii* \[[@B3-molecules-22-00860]\]. Thus, the structure of **3** is 14:16,15:20,18:20-triepoxy-5α:9α-peroxy-14,15-secopregn-6,8(14)-dien-3β-yl-4-*O*-\[4-*O*-(4-*O*-α-[l]{.smallcaps}-diginopyranosoyl-β-[d]{.smallcaps}-cymaropyranosyl)-β-[d]{.smallcaps}-digitoxopyranosyl\]-β-[d]{.smallcaps}-thevetopyranoside and named stauntoside UA~2~.

3. Experimental Section {#sec3-molecules-22-00860}
=======================

3.1. General Experimental Procedures {#sec3dot1-molecules-22-00860}
------------------------------------

All the instruments, solvents, reagents, and experimental conditions for the measurements of IR spectra, 1D and 2D NMR spectra, and both ESIMS and HRESIMS data and for the performing of column chromatography (CC), preparative HPLC procedure, and TLC analysis were previously described \[[@B2-molecules-22-00860],[@B3-molecules-22-00860]\].

3.2. Plant Material {#sec3dot2-molecules-22-00860}
-------------------

The collecting, species identifying, and depositing of the roots of *C. stauntonii* were previously described \[[@B2-molecules-22-00860],[@B3-molecules-22-00860]\].

3.3. Extraction and Isolation {#sec3dot3-molecules-22-00860}
-----------------------------

The extraction of the dried and pulverized roots (30 kg) of *C. stauntonii* and the preliminary isolation of the 95% EtOH extract and the consequent EtOAc-soluble portion to afford thirteen subfractions (Fr. 1 to Fr. 13) of silica gel CC fractionation were previously described \[[@B2-molecules-22-00860],[@B3-molecules-22-00860]\]. Fr. 3 (68.0 g; eluted with CHCl~3~:MeOH, 100:1, *v*/*v*) was separated with silica gel CC using a gradient elution of petroleum ether:EtOA (25:1→1:1, *v*/*v*) to yield seven subfractions, Fr. 3-1 to Fr. 3-7. Fr. 3-5 (5.0 g; eluted with petroleum ether:EtOAc, 10:1, *v*/*v*) was subjected to a flash C~18~ column eluted with a gradient of MeOH:H~2~O (40:60→100:0, *v*/*v*) to yield six subfractions, Fr. 3-5-1 to Fr. 3-5-6. Fr. 3-5-4 (sampled 150 mg; eluted with MeOH:H~2~O, 60:40, *v*/*v*) was subjected to preparative RP-HPLC (mobile phase of MeCN:H~2~O (38:62, *v*/*v*) at a flow rate of 5 mL min^−1^ with UV detection at 280 nm) to yield, in addition to the reported known compound \[[@B3-molecules-22-00860]\], compound **1** (15 mg). Fr. 5 (12.0 g; eluted with CHCl~3~:MeOH, 50:1, *v*/*v*) was subjected to a flash C~18~ column eluted with a gradient of MeOH:H~2~O (40:60→100:0, *v*/*v*) to yield five subfractions, Fr. 5-1 to Fr. 5-5. Fr. 5-4 (6.0 g; eluted with MeOH:H~2~O, 70:30, *v*/*v*) was subjected to a flash C~18~ column eluted with a gradient of MeOH:H~2~O (40:60→100:0, *v*/*v*) to yield five subfractions, Fr. 5-4-1 to Fr. 5-4-5. Fr. 5-4-4 (sampled 800 mg, eluted with MeOH:H~2~O, 70:30, *v*/*v*) was subjected to preparative RP-HPLC (mobile phase of CH~3~CN:H~2~O (38:62, *v*/*v*) at a flow rate of 5 mL min^-1^ with UV detection at 280 nm) to yield compound **2** (17 mg). Fr. 8 (6.0 g, eluted with CHCl~3~:MeOH, 25:1, *v*/*v*) was subjected to a flash C~18~ column eluted with a gradient of MeOH:H~2~O (40:60→100:0, *v*/*v*) to yield five subfractions, Fr. 8-1 to Fr. 8-5. Fr. 8-2 (sampled 300 mg, eluted with MeOH:H~2~O, 50:50, *v*/*v*) was subjected to preparative RP-HPLC (mobile phase of CH~3~CN:H~2~O (35:65, *v*/*v*) at a flow rate of 5 mL min^−1^ with UV detection at 280 nm) to yield compound **3** (10 mg).

Stauntoside UA (**1**). White amorphous powder; IR (KBr) ν~max~ 3440, 2933, 1681, 1450, 1379, 1163, 1095, 1060, 942, and 835 cm^−1^; for ^1^H-NMR (500 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; for ^13^C-NMR (125 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; positive-ion mode ESIMS *m*/*z* 801.5 \[M + Na\]^+^; positive-ion mode HRESIMS *m*/*z* 779.3861 \[M + H\]^+^ (calculated for C~40~H~59~O~15~, 779.3848), *m*/*z* 801.3694 \[M + Na\]^+^ (calculated for C~40~H~58~O~15~Na, 801.3668).

Stauntoside UA~1~ (**2**). White amorphous powder; IR (KBr) ν~max~: 3393, 2921, 1646, 1468, 1380, 1160, 1104, 1063, 1007, and 721 cm^−1^; for ^1^H-NMR (500 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; for ^13^C-NMR (125 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; positive-ion mode ESIMS *m*/*z* 989.5 \[M + Na\]^+^; positive-ion mode HRESIMS *m*/*z* 989.4729 \[M + Na\]^+^ (calculated for C~49~H~74~O~19~Na, 989.4717).

Stauntoside UA~2~ (**3**). White amorphous powder; IR (KBr) *ν*~max~: 3369, 2924, 1662, 1465, 1380, 1165, 1065, 1023, and 879 cm^−1^; for ^1^H-NMR (500 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; for ^13^C-NMR (125 MHz), see [Table 1](#molecules-22-00860-t001){ref-type="table"} and [Table 2](#molecules-22-00860-t002){ref-type="table"}; positive-ion mode ESIMS *m*/*z* 975.5 \[M + Na\]^+^; positive-ion mode HRESIMS *m*/*z* 975.4567 \[M + Na\]^+^ (calculated for C~48~H~72~O~19~Na, 975.4560).

3.4. Determination of Steroidal Category and 2-Deoxysugars {#sec3dot4-molecules-22-00860}
----------------------------------------------------------

### 3.4.1. Libermann-Burchard Reaction {#sec3dot4dot1-molecules-22-00860}

To a solution of each compound (1 mg) in acetic anhydride (5 mL) was added a little of a mixture of 98% sulfuric acid and acetic anhydride (1:20, *v*/*v*) dropwise. An obvious color change from somewhat yellowish red to purple to blue to dark reddish brown was observed.

### 3.4.2. Keller-Kiliani Reaction {#sec3dot4dot2-molecules-22-00860}

To a solution of each compound (1 mg) in acetic acid (5 mL) was added one drop of aqueous 20% FeCl~3~ solution. The solution was fully mixed and then a spot of 98% sulfuric acid was added along the test tube wall, with a light green color being observed in the acetic acid solution.

3.5. Acid Hydrolysis of New Compounds and Determination of Absolute Configurations of Monosaccharides {#sec3dot5-molecules-22-00860}
-----------------------------------------------------------------------------------------------------

The acid hydrolysis of new compounds and determination of absolute configurations of monosaccharides were conducted using the method described in a previous paper from our laboratory \[[@B2-molecules-22-00860],[@B16-molecules-22-00860]\]. In this experiment, the known compounds stauntoside B, glaucogenin C mono-[d]{.smallcaps}-thevetoside, stauntoside G, and amplexicoside D were used to determine the retention times of the acetylated thiazolidine derivatives of relevant monosaccharides, with *t*~R~ [d]{.smallcaps}-digitoxose 13.09 min, *t*~R~ [l]{.smallcaps}-cymarose 13.46 min, *t*~R~ [d]{.smallcaps}-cymarose 18.46 min, *t*~R~ [l]{.smallcaps}-diginose 14.31 min, *t*~R~ [d]{.smallcaps}-thevetose 16.07 min, and *t*~R~ [d]{.smallcaps}-canarose 16.51 min being determined. Retention times of the monosaccharides released from the new compounds after derivatization were as follows: *t*~R~ [d]{.smallcaps}-digitoxose 13.05 min, *t*~R~ [l]{.smallcaps}-cymarose 13.41 min, and *t*~R~ [d]{.smallcaps}-canarose 16.45 min for compound **1**; *t*~R~ [d]{.smallcaps}-cymarose 18.49 min, *t*~R~ [l]{.smallcaps}-diginose 14.38 min, and *t*~R~ [d]{.smallcaps}-thevetose 16.09 min for compound **2**; and *t*~R~ [d]{.smallcaps}-digitoxose 13.06 min, *t*~R~ [d]{.smallcaps}-cymarose 18.42 min, *t*~R~ [l]{.smallcaps}-diginose 14.38 min, and *t*~R~ [d]{.smallcaps}-thevetose 16.03 min for compound **3**.
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molecules-22-00860-t001_Table 1

###### 

^1^H- and ^13^C-NMR spectroscopic data for the aglycone moieties of **1**--**3** (in pyridine-*d*~5~, TMS).

  Position   1                         2       3                                                     
  ---------- ------------------------- ------- ---------------------- ------- ---------------------- -------
  1α         1.34, ov                  27.6    1.32, ov               28.9    1.32, ov               27.4
  1β         2.10, ov                          2.10, ov                       1.91, ov               
  2α         2.23, br dd (14.0, 2.5)   30.2    2.39, ov               31.4    2.23, ov               29.9
  2β         2.08, ov                          2.10, ov                       2.07, ov               
  3          4.31, m                   73.3    4.23, m                74.9    4.31, m                73.4
  4α         2.51, ov                  33.6    2.52, dd (14.0, 4.5)   34.7    2.52, dd (14.0, 5.0)   33.2
  4β         1.96, ov                          1.75, ov                       1.76, ov               
  5                                    85.6                           86.8                           85.3
  6          5.59, d (9.5)             129.1   5.48, d (9.5)          130.3   5.48, d (9.5)          128.8
  7          6.77, d (9.5)             125.1   6.72, d (9.5)          126.4   6.72, d (9.5)          124.8
  8                                    110.4                          111.7                          110.1
  9                                    87.4                           88.6                           87.1
  10                                   50.6                           51.9                           50.4
  11α        2.01, ov                  24.7    2.00, ov               25.9    2.00, ov               24.4
  11β        1.77, ov                          1.72, ov                       1.75, ov               
  12a        2.10, ov                  28.4    2.01, ov               29.7    2.08, ov               28.2
  12b        1.92, ov                          1.92, ov                       1.91, ov               
  13                                   55.0                           56.2                           54.7
  14                                   156.8                          158.1                          156.6
  15α        3.79, dd (11.0, 4.5)      72.0    3.79, dd (11.0, 4.5)   73.2    3.79, dd (11.0, 4.5)   71.7
  15β        4.24, ov                          4.24, br d (11.0)              4.09, br d (11.0)      
  16         4.81, ov                  86.9    4.81, ov               88.2    4.81, ov               86.7
  17         2.81, d (7.5)             61.9    2.80, d (8.0)          63.1    2.80, d (8.0)          61.6
  18a        3.99, d (9.0)             75.3    3.98, d (10.0)         76.5    3.98, d (8.5)          75.0
  18b        4.11, d (9.0)                     4.10, d (10.0)                 4.09, d (8.5)          
  19         0.95, s                   15.8    0.89, s                17.0    0.89, s                15.5
  20                                   118.4                          119.6                          118.2
  21         1.54, s                   22.4    1.54, s                23.7    1.54, s                22.2

ov: overlapped signals.

molecules-22-00860-t002_Table 2

###### 

^1^H- and ^13^C-NMR spectroscopic data for the sugar moieties of **1**--**3** (pyridine-*d*~5~).

  Position       1                        2        3                                                         
  -------------- ------------------------ -------- ------------------------ ------- ------------------------ ---------
                 β-[d]{.smallcaps}-can             β-[d]{.smallcaps}-the            β-[d]{.smallcaps}-the    
  1′             4.76, dd (9.5, 2.0)      98.8     4.74, d (8.0)            103.9   4.73, d (8.0)            102.4
  2′a            2.51, ov                 40.1     3.91, ov                 75.9    3.91, ov                 74.4
  2′b            1.96, ov                                                                                    
  3′             3.95, ov                 70.1     3.66, ov                 86.1    3.67, ov                 85.6
  4′             3.28, ov                 88.5     3.67, ov                 83.9    3.69, ov                 82.6
  5\'            3.47, ov                 70.9     3.61, ov                 72.9    3.69, ov                 71.4
  6′             1.31, d (6.5)            18.1     1.42, d (5.5)            19.9    1.42, d (6.0)            18.4
  3′-OCH~3~                                        3.92, s                  61.8    3.93, s                  60.3
                 β-[d]{.smallcaps}-digt            β-[d]{.smallcaps}-cym            β-[d]{.smallcaps}-digt   
  1′′            5.24, dd (9.5, 2.0)      99.9     5.30, dd (10.0, 2.0)     100.1   5.55, dd (10.0, 2.0)     98.7
  2′′a           2.41, ov                 38.2     1.85, ov                 38.4    1.99, ov                 38.9
  2′′b           1.96, ov                          2.35, ov                         2.42, ov                 
  3′′            4.48, ov                 67.4     4.07, ov                 79.4    4.63, ov                 67.5
  4′′            3.43, ov                 80.7     3.48, dd (10.0, 3.0)     84.5    3.47, ov                 83.0
  5′′            4.19, ov                 69.4     4.21, ov                 70.6    4.29, ov                 68.6
  6′′            1.31, d (6.5)            18.1     1.37, d (6.0)            19.9    1.41, d (6.0)            18.3
  3′′-OCH~3~                                       3.61, s                  60.1                             
                 α-[l]{.smallcaps}-cym             β-[d]{.smallcaps}-cym            β-[d]{.smallcaps}-cym    
  1′′′           5.04, dd (4.0, 3.0)      98.6     5.08, dd (9.5, 1.5)      101.5   5.13, br d (9.5)         99.4
  2′′′a          2.34, ov                 32.2     1.74, ov (2.42)          36.4    1.68, ov                 34.7~2~
  2′′′b          1.82, ov                          2.42, ov                         2.32, ov                 
  3′′′           3.79, ov                 76.5     3.96, ov                 78.8    3.92, ov                 77.2
  4′′′           3.61, ov                 72.6     3.45, dd (10.0, 1.0)     83.5    3.39, ov                 82.0
  5′′′           4.48, ov                 67.6     4.21, ov                 70.6    4.21, ov                 69.1
  6′′′           1.41, d (6.5)            18\. 4   1.37, d (6.0)            19.7    1.30, d (6.0)            18.4
  3′′′-OCH~3~    3.37, s                  56.8     3.52, s                  58.6    3.52, s                  57.1
                                                   α-[l]{.smallcaps}-dign           α-[l]{.smallcaps}-dign   
  1′′′′                                            5.22, br d (3.0)         102.4   5.19, br d (3.5)         101.0
  2′′′′a                                           2.09, ov                 32.2    2.07, ov                 30.7
  2′′′′b                                           2.39, ov                         2.37, ov                 
  3′′′′                                            3.85, ov                 77.1    3.84, ov                 75.6
  4′′′′                                            4.07, ov                 68.9    4.07, ov                 67.4
  5′′′′                                            4.32, ov                 68.8    4.30, ov                 67.5
  6′′′′                                            1.57, d (6.5)            19.0    1.56, d (7.0)            17.5
  3′′′′-OCH~3~                                     3.31, s                  56.3    3.31, s                  54.8

ov: overlapped signals.
